Pharma Focus Asia

Eurofins Invests US$169 million to Expand the Chemistry Site in Spain

Introduction:
Eurofins with an investment of US$169 million plans for expansion of the chemistry site for the synthesis of chemicals and purification of drugs. The new manufacturing facility will be located in Murcia, Spain.

Features:
The state-of-the-art facility will be designed with a huge area covering 63,000 square. The new facility will double the size of existing capacity by expanding the current chemistry services capacity for drug discovery and thus enabling the synthesis and chemical purification of drugs initially.

The design principles of the new site make use of modern and functional design in optimising sample and supply flows within laboratories. New site will also offer chemistry capacity and capabilities by enabling new, associated services.

The completion of the project is expected to start its operations in early 2021.

NameEurofins
Type   Expansion
BudgetUS$169 million
Year2021

 

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference